Harel Insurance Investments & Financial Services’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-255
Closed -$72K 661
2023
Q2
$72K Sell
255
-206
-45% -$61.3K ﹤0.01% 428
2023
Q1
$127K Buy
461
+123
+36% +$34K ﹤0.01% 381
2022
Q4
$93K Sell
338
-1,462
-81% -$413K ﹤0.01% 375
2022
Q3
$476K Buy
+1,800
New +$382K 0.01% 222
2022
Q1
Sell
-4
Closed -$1K 714
2021
Q4
$1K Sell
4
-164
-98% -$42.2K ﹤0.01% 737
2021
Q3
$48K Buy
168
+35
+26% +$11.5K ﹤0.01% 537
2021
Q2
$46K Hold
133
﹤0.01% 710
2021
Q1
$37K Sell
133
-1,571
-92% -$424K ﹤0.01% 654
2020
Q4
$1.34M Sell
1,704
-133
-7% -$34.3K 0.03% 247
2020
Q3
$521K Buy
1,837
+728
+66% +$203K 0.02% 193
2020
Q2
$297K Buy
1,109
+16
+1% +$4.81K 0.01% 198
2020
Q1
$346K Buy
1,093
+388
+55% +$118K 0.02% 124
2019
Q4
$209K Buy
705
+527
+296% +$146K 0.01% 194
2019
Q3
$41K Buy
+178
New +$41.4K ﹤0.01% 322
2019
Q2
Sell
-100
Closed -$24K 468
2019
Q1
$24K Sell
100
-700
-88% -$220K ﹤0.01% 346
2018
Q4
$241K Sell
800
-900
-53% -$287K 0.01% 162
2018
Q3
$601K Buy
1,700
+1,100
+183% +$379K 0.03% 131
2018
Q2
$174K Buy
600
+200
+50% +$56.2K 0.01% 195
2018
Q1
$110K Hold
400
0.01% 256
2017
Q4
$127K Buy
400
+174
+77% +$55.8K 0.01% 249
2017
Q3
$71K Hold
226
0.01% 261
2017
Q2
$61K Sell
226
-80
-26% -$21.2K ﹤0.01% 282
2017
Q1
$84K Buy
+306
New +$86.5K 0.01% 231

Other funds holding BIIB

Harel Insurance Investments & Financial Services's BIIB Position: Q3 2023 in Review

Harel Insurance Investments & Financial Services sold out of Biogen (BIIB) in Q3 2023, closing a stake of 255 shares — an estimated $72K sold.

Harel Insurance Investments & Financial Services first reported a position in BIIB in Q1 2017 and held it in 23 quarters. The position peaked at $1.34M in Q4 2020. 966 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

  • Harel Insurance Investments & Financial Services reported no remaining Biogen position as of Q3 2023 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 255 Biogen shares in Q3 2023, an estimated $72K.
  • Harel Insurance Investments & Financial Services first reported a position in Biogen in Q1 2017 and held it in 23 quarters.
  • Harel Insurance Investments & Financial Services's Biogen position peaked at $1.34M in Q4 2020.
  • 966 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q3 2023, filed 30 Oct 2023.